Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD.

Lee J, McCulloch CE, Flynn JT, Samuels J, Warady BA, Furth SL, Seth D, Grimes BA, Mitsnefes MM, Ku E.

Clin J Am Soc Nephrol. 2020 Mar 11. pii: CJN.10130819. doi: 10.2215/CJN.10130819. [Epub ahead of print]

PMID:
32160993
2.

Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.

Denburg MR, Razzaghi H, Bailey LC, Soranno DE, Pollack AH, Dharnidharka VR, Mitsnefes MM, Smoyer WE, Somers MJG, Zaritsky JJ, Flynn JT, Claes DJ, Dixon BP, Benton M, Mariani LH, Forrest CB, Furth SL.

J Am Soc Nephrol. 2019 Dec;30(12):2427-2435. doi: 10.1681/ASN.2019040365. Epub 2019 Nov 15.

PMID:
31732612
3.

Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD.

Saland JM, Kupferman JC, Pierce CB, Flynn JT, Mitsnefes MM, Warady BA, Furth SL.

Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1711-1718. doi: 10.2215/CJN.03110319. Epub 2019 Nov 11.

PMID:
31712386
4.

Cardiovascular disease in young adults with incident ESRD.

Ku E, Mitsnefes MM.

Nat Rev Nephrol. 2019 Jul;15(7):390-391. doi: 10.1038/s41581-019-0154-3. No abstract available.

PMID:
31043718
5.

Association between BMI changes and mortality risk in children with end-stage renal disease.

Roberts MJ, Mitsnefes MM, McCulloch CE, Greenbaum LA, Grimes BA, Ku E.

Pediatr Nephrol. 2019 Sep;34(9):1557-1563. doi: 10.1007/s00467-019-04249-z. Epub 2019 Apr 8.

PMID:
30963283
6.

When to Initiate Dialysis in Children and Adolescents: Is Waiting Worthwhile?

Nehus E, Mitsnefes MM.

Am J Kidney Dis. 2019 Jun;73(6):762-764. doi: 10.1053/j.ajkd.2019.02.008. Epub 2019 Apr 5. No abstract available.

PMID:
30955943
7.

Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.

de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, Mietus-Snyder M, Mitsnefes MM, Peterson AL, St-Pierre J, Urbina EM, Zachariah JP, Zaidi AN.

Circulation. 2019 Mar 26;139(13):e603-e634. doi: 10.1161/CIR.0000000000000618.

PMID:
30798614
8.

Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients.

Mitsnefes MM, Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Monroy-Trujillo JM, Zhang W, Setchell K, Parekh RS.

J Clin Lipidol. 2018 Nov - Dec;12(6):1513-1522.e4. doi: 10.1016/j.jacl.2018.07.011. Epub 2018 Jul 30.

PMID:
30143433
9.

Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children.

Lalan S, Jiang S, Ng DK, Kupferman F, Warady BA, Furth S, Mitsnefes MM.

J Pediatr. 2018 Nov;202:163-170. doi: 10.1016/j.jpeds.2018.06.007. Epub 2018 Jul 2.

10.

Cardiac MRI assessment in children and young adults with end-stage renal disease
.

Avendt MB, Taylor MD, Mitsnefes MM.

Clin Nephrol. 2018 Sep;90(3):172-179. doi: 10.5414/CN109271.

PMID:
29974855
11.

Twenty-Four-Hour Ambulatory Blood Pressure versus Clinic Blood Pressure Measurements and Risk of Adverse Outcomes in Children with CKD.

Ku E, McCulloch CE, Warady BA, Furth SL, Grimes BA, Mitsnefes MM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):422-428. doi: 10.2215/CJN.09630917. Epub 2018 Feb 13.

12.

The management of pediatric renovascular hypertension: a single center experience and review of the literature.

Lobeck IN, Alhajjat AM, Dupree P, Racadio JM, Mitsnefes MM, Karns R, Tiao GM, Nathan JD.

J Pediatr Surg. 2018 Sep;53(9):1825-1831. doi: 10.1016/j.jpedsurg.2017.12.008. Epub 2017 Dec 24. Review.

PMID:
29397961
13.

Blood pressure control over time in childhood-onset systemic lupus erythematous.

Avar Aydin PO, Shan J, Brunner HI, Mitsnefes MM.

Lupus. 2018 Apr;27(4):657-664. doi: 10.1177/0961203317751061. Epub 2018 Jan 4.

PMID:
29301473
14.

Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.

Winnicki E, McCulloch CE, Mitsnefes MM, Furth SL, Warady BA, Ku E.

JAMA Pediatr. 2018 Feb 1;172(2):174-180. doi: 10.1001/jamapediatrics.2017.4083.

15.

Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.

Foster BJ, Mitsnefes MM, Dahhou M, Zhang X, Laskin BL.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):91-99. doi: 10.2215/CJN.04330417. Epub 2017 Dec 14.

16.

FGF23 and Left Ventricular Hypertrophy in Children with CKD.

Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):45-52. doi: 10.2215/CJN.02110217. Epub 2017 Oct 12.

17.

Clinical outcomes and survival in pediatric patients initiating chronic dialysis: a report of the NAPRTCS registry.

Weaver DJ Jr, Somers MJG, Martz K, Mitsnefes MM.

Pediatr Nephrol. 2017 Dec;32(12):2319-2330. doi: 10.1007/s00467-017-3759-4. Epub 2017 Jul 31.

PMID:
28762101
18.

Ambulatory Blood Pressure Control in Children and Young Adults After Kidney Transplantation.

Hamdani G, Nehus EJ, Hanevold CD, VanSickle JS, Hooper DK, Blowey D, Warady BA, Mitsnefes MM.

Am J Hypertens. 2017 Oct 1;30(10):1039-1046. doi: 10.1093/ajh/hpx092.

19.

Kidney outcomes three years after bariatric surgery in severely obese adolescents.

Nehus EJ, Khoury JC, Inge TH, Xiao N, Jenkins TM, Moxey-Mims MM, Mitsnefes MM.

Kidney Int. 2017 Feb;91(2):451-458. doi: 10.1016/j.kint.2016.09.031. Epub 2016 Dec 1.

PMID:
27914704
20.

Masked hypertension and allograft function in pediatric and young adults kidney transplant recipients.

Hamdani G, Nehus EJ, Hooper DK, Mitsnefes MM.

Pediatr Transplant. 2016 Dec;20(8):1026-1031. doi: 10.1111/petr.12752. Epub 2016 Jun 28.

PMID:
27353352
21.

Hypertension in chronic kidney disease: role of ambulatory blood pressure monitoring.

VanDeVoorde RG 3rd, Mitsnefes MM.

Prog Pediatr Cardiol. 2016 Jun;41:67-73. Epub 2015 Dec 17.

22.

Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation.

Hamdani G, Nehus EJ, Hanevold CD, Sebestyen Van Sickle J, Woroniecki R, Wenderfer SE, Hooper DK, Blowey D, Wilson A, Warady BA, Mitsnefes MM.

Transplantation. 2017 Jan;101(1):150-156. doi: 10.1097/TP.0000000000001087.

23.

Can office blood pressure readings predict masked hypertension?

Mitsnefes MM, Pierce C, Flynn J, Samuels J, Dionne J, Furth S, Warady B; CKiD study group.

Pediatr Nephrol. 2016 Jan;31(1):163-6. doi: 10.1007/s00467-015-3212-5. Epub 2015 Sep 28.

24.

Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.

Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ.

Am J Kidney Dis. 2015 Dec;66(6):984-92. doi: 10.1053/j.ajkd.2015.06.015. Epub 2015 Jul 21.

25.

Subclinical kidney injury before and 1 year after bariatric surgery among adolescents with severe obesity.

Xiao N, Devarajan P, Inge TH, Jenkins TM, Bennett M, Mitsnefes MM.

Obesity (Silver Spring). 2015 Jun;23(6):1234-8. doi: 10.1002/oby.21070. Epub 2015 May 9.

26.

Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study.

Riar SK, Mitsnefes MM, Nehus EJ, Patel HP, Steinke JM, Crumb T, Abraham EC, Kamel MW, Greenbaum LA.

Pediatr Nephrol. 2015 Aug;30(8):1343-8. doi: 10.1007/s00467-015-3066-x. Epub 2015 Mar 8.

PMID:
25750075
27.

Assessment and management of hypertension in transplant patients.

Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A, Mitsnefes MM, Sica DA, Taler SJ.

J Am Soc Nephrol. 2015 Jun;26(6):1248-60. doi: 10.1681/ASN.2014080834. Epub 2015 Feb 4. Review.

28.

Kidney function in severely obese adolescents undergoing bariatric surgery.

Xiao N, Jenkins TM, Nehus E, Inge TH, Michalsky MP, Harmon CM, Helmrath MA, Brandt ML, Courcoulas A, Moxey-Mims M, Mitsnefes MM; Teen-LABS Consortium.

Obesity (Silver Spring). 2014 Nov;22(11):2319-25. doi: 10.1002/oby.20870.

29.

The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States.

Laskin BL, Mitsnefes MM, Dahhou M, Zhang X, Foster BJ.

Kidney Int. 2015 Mar;87(3):575-83. doi: 10.1038/ki.2014.342. Epub 2014 Oct 15.

30.

Coronary artery calcification and cardiovascular disease in children with chronic kidney disease.

Paoli S, Mitsnefes MM.

Curr Opin Pediatr. 2014 Apr;26(2):193-7. doi: 10.1097/MOP.0000000000000059. Review.

31.

Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease.

Kogon AJ, Pierce CB, Cox C, Brady TM, Mitsnefes MM, Warady BA, Furth SL, Flynn JT.

Kidney Int. 2014 Apr;85(4):938-44. doi: 10.1038/ki.2013.352. Epub 2013 Sep 18.

32.

Ambulatory arterial stiffness index: Is there an additional value to characterize cardiovascular risk in children with kidney transplant?

Mitsnefes MM.

Pediatr Transplant. 2013 Nov;17(7):595-7. doi: 10.1111/petr.12142. Epub 2013 Aug 28. No abstract available.

PMID:
24033983
33.

Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010.

Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ.

JAMA. 2013 May 8;309(18):1921-9. doi: 10.1001/jama.2013.4208.

34.

Management of blood pressure in children.

Malatesta-Muncher R, Mitsnefes MM.

Curr Opin Nephrol Hypertens. 2012 May;21(3):318-22. doi: 10.1097/MNH.0b013e328351c415. Review.

35.

Cardiovascular disease in children with chronic kidney disease.

Mitsnefes MM.

J Am Soc Nephrol. 2012 Apr;23(4):578-85. doi: 10.1681/ASN.2011111115. Epub 2012 Mar 1. Review.

36.

Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.

Wilson AC, Schneider MF, Cox C, Greenbaum LA, Saland J, White CT, Furth S, Warady BA, Mitsnefes MM.

Clin J Am Soc Nephrol. 2011 Dec;6(12):2759-65. doi: 10.2215/CJN.03010311. Epub 2011 Oct 6.

37.

Cardiovascular complications in children with chronic kidney disease.

Shroff R, Weaver DJ Jr, Mitsnefes MM.

Nat Rev Nephrol. 2011 Sep 13;7(11):642-9. doi: 10.1038/nrneph.2011.116. Review.

PMID:
21912426
38.

Hypertension and CKD.

VanDeVoorde RG, Mitsnefes MM.

Adv Chronic Kidney Dis. 2011 Sep;18(5):355-61. doi: 10.1053/j.ackd.2011.03.003. Review.

PMID:
21896377
39.

Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease.

Lo MM, Salisbury S, Scherer PE, Furth SL, Warady BA, Mitsnefes MM.

Pediatr Nephrol. 2011 Nov;26(11):2009-17. doi: 10.1007/s00467-011-1906-x. Epub 2011 May 8.

40.

Dyslipidemia in children with chronic kidney disease.

Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, Warady BA, Furth SL; CKiD Investigators.

Kidney Int. 2010 Dec;78(11):1154-63. doi: 10.1038/ki.2010.311. Epub 2010 Aug 25.

41.

Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Wilson AC, Mitsnefes MM.

Am J Kidney Dis. 2009 Aug;54(2):345-60. doi: 10.1053/j.ajkd.2009.04.027. Review.

42.

Antihypertensive prescription in pediatric dialysis: a practitioner survey by the Midwest Pediatric Nephrology Consortium study.

Lin JJ, Mitsnefes MM, Smoyer WE, Valentini RP.

Hemodial Int. 2009 Jul;13(3):307-15. doi: 10.1111/j.1542-4758.2009.00392.x. Epub 2009 Jul 15.

PMID:
19614781
43.

Cardiac output and associated left ventricular hypertrophy in pediatric chronic kidney disease.

Weaver DJ Jr, Kimball TR, Koury PR, Mitsnefes MM.

Pediatr Nephrol. 2009 Mar;24(3):565-70. doi: 10.1007/s00467-008-1052-2. Epub 2008 Dec 2.

PMID:
19048301
44.

Subclinical systolic dysfunction in pediatric patients with chronic kidney disease.

Weaver DJ Jr, Kimball T, Witt SA, Glascock BJ, Khoury PR, Kartal J, Mitsnefes MM.

J Pediatr. 2008 Oct;153(4):565-9. doi: 10.1016/j.jpeds.2008.04.026. Epub 2008 May 27.

PMID:
18534216
45.

Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy.

Nguyen MT, Dent CL, Ross GF, Harris N, Manning PB, Mitsnefes MM, Devarajan P.

Pediatr Nephrol. 2008 Aug;23(8):1317-26. doi: 10.1007/s00467-008-0827-9. Epub 2008 May 28.

PMID:
18506488
46.

Acquired renal cysts after pediatric liver transplantation: association with cyclosporine and renal dysfunction.

Calvo-Garcia MA, Campbell KM, O'Hara SM, Khoury P, Mitsnefes MM, Strife CF.

Pediatr Transplant. 2008 Sep;12(6):666-71. doi: 10.1111/j.1399-3046.2007.00872.x. Epub 2008 Mar 6.

PMID:
18331544
47.

Understanding carotid artery intima-media thickness in childhood: lessons from studies in children with renal transplants.

Mitsnefes MM.

Pediatr Transplant. 2008 Jun;12(4):377-80. doi: 10.1111/j.1399-3046.2007.00892.x. Epub 2008 Jan 14. No abstract available.

PMID:
18208438
48.

Decreased maximal aerobic capacity in pediatric chronic kidney disease.

Weaver DJ Jr, Kimball TR, Knilans T, Mays W, Knecht SK, Gerdes YM, Witt S, Glascock BJ, Kartal J, Khoury P, Mitsnefes MM.

J Am Soc Nephrol. 2008 Mar;19(3):624-30. doi: 10.1681/ASN.2007070773. Epub 2008 Jan 9.

49.
50.

Ambulatory blood pressure monitoring: a quest for truth.

VanDe Voorde RG, Mitsnefes MM.

Pediatr Transplant. 2007 Feb;11(1):10-3. No abstract available. Erratum in: Pediatr Transplant. 2007 May;11(3):345.

PMID:
17239117

Supplemental Content

Loading ...
Support Center